NOW LIVE: Meet the new all-in-one platform for medical record reviews! Learn more
Company Updates
xx
Min Read

DigitalOwl and RGA: Advancing Data-Powered Automation in Life and Health

Published On
February 28, 2024
Share this post
https://digitalowl.com/digitalowl-and-rga-advancing-data-powered-automation-in-life-and-health

As the CEO of DigitalOwl, my commitment to innovation and excellence is unwavering, especially when it comes to advancing our AI-powered offerings. That’s why I’m excited to share with our community the strategic investment we’ve received from RGA, a global leader in life and health reinsurance. Announced earlier this year, this life and health partnership is a testament to our shared vision for the responsible digitization of health data automation and stands as evidence of the quality and reliability of our product.

DigitalOwl and RGA employees share a meal.

Revolutionizing AI in Life and Health Insurance

This collaboration heralds a new era of innovation, positioning both DigitalOwl and RGA at the forefront of the digital revolution in the insurance industry. By combining DigitalOwl’s cutting-edge technology with RGA’s comprehensive expertise and deep-rooted industry knowledge, this partnership is set to redefine the standards of insurance underwriting, risk assessment and claims processing - setting a new bar for underwriting efficiency.

Watch this video to learn how our partnership with RGA will revolutionize medical record summarizations.

Selecting RGA: A Strategic Decision for Enhanced Insurance Underwriting

RGA is a trailblazer in underwriting innovation. Together, we will be better equipped to transform large amounts of complex health data into actionable insights for more efficient risk assessments, enabling DigitalOwl to enhance our product development, refine our proprietary AI models, and expand our market reach. The partnership will also facilitate our entry into new segments within the life and health insurance markets, leveraging RGA's established reputation and client base. This is a pivotal moment for DigitalOwl as we continue redefining the boundaries of what’s possible within the insurance industry.

In turn, the partnership will enable RGA to advance automated underwriting with structured data. RGA will integrate our cutting-edge technology throughout their workflows for a smarter, faster analysis of medical data.

“This relationship enables RGA to give our clients a fully digital experience. This means a commitment to structured data for leveraging insights, unparalleled degrees of automation, and setting a new bar for underwriting efficiencies,” said Dave Rengachary, SVP and Head of Underwriting for RGA’s U.S. Individual Life business.

DigitalOwl CEO, Yuval Man, and RGA SVP and Head of Underwriting, Dave Rengachary, make a toast.

Prioritizing AI Data Privacy and Security

In every discussion of DigitalOwl’s burgeoning partnerships, I believe it’s crucial to address our unwavering commitment to our client’s data security and privacy. Upholding the confidentiality and integrity of our customers’ data remains our top priority. Furthermore, RGA’s discerning approach to AI integration and adoption complements our stringent security measures, ensuring a partnership that will foster responsible innovation.

DigitalOwl remains an independent, separate entity committed to our original mission and values. While our partnership with RGA enhances our capabilities, it does not change our identity or the way we operate. You will continue to receive the same high-quality service directly from us.

Conclusion

Together with RGA, we’re stepping boldly but responsibly forward into the world of generative AI, to offer faster, smarter, and more streamlined assessments.

Learn more about this collaboration at rgare.com/digitalowl.

Yuval Man
Co-Founder & CEO
,
DigitalOwl
About the author

As the Co-Founder & CEO of DigitalOwl, Yuval Man empowers insurance companies to unlock the full potential of their medical data for better outcomes by harnessing the transformative powers of AI to streamline and elevate the review of medical data.